|
HDAC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.449400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.311350E-01 |
| Normal-vs-Stage2 |
1.283210E-01 |
| Normal-vs-Stage3 |
3.054800E-01 |
| Normal-vs-Stage4 |
8.929600E-01 |
| Stage1-vs-Stage2 |
5.028000E-01 |
| Stage1-vs-Stage3 |
1.883970E-02 |
| Stage1-vs-Stage4 |
2.716200E-01 |
| Stage2-vs-Stage3 |
2.464300E-02 |
| Stage2-vs-Stage4 |
1.774030E-01 |
| Stage3-vs-Stage4 |
5.405600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.557600E-01 |
| Normal-vs-AfricanAmerican |
1.539210E-01 |
| Normal-vs-Asian |
5.105200E-01 |
| Caucasian-vs-AfricanAmerican |
8.878300E-02 |
| Caucasian-vs-Asian |
5.005800E-01 |
| AfricanAmerican-vs-Asian |
3.417000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.062400E-01 |
| Normal-vs-Female |
2.902800E-01 |
| Male-vs-Female |
5.894600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.954030E-01 |
| Normal-vs-Age(41-60Yrs) |
6.150800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.836400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.348800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.184200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.458200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.135200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.207200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.574400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.928000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.119600E-03 |
| Classical-VS-Follicular |
3.588700E-04 |
| Classical-VS-Other |
3.413200E-01 |
| Classical-VS-Normal |
7.775800E-01 |
| Tall-VS-Follicular |
3.06180000020362E-07 |
| Tall-VS-Other |
1.746260E-02 |
| Tall-VS-Normal |
4.761200E-03 |
| Follicular-VS-Other |
6.625000E-01 |
| Follicular-VS-Normal |
5.211500E-04 |
| Other-VS-Normal |
3.851400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.844100E-02 |
| Normal-vs-N1 |
2.377400E-01 |
| N0-vs-N1 |
1.913830E-02 |
|
|
